Dr. Dylan Brock received his Bachelor of Arts in Neuroscience and Philosophy of Mind from New York University. He attended medical school at the University of Louisville, where he simultaneously completed a Masters in Bioethics. He completed his residency in Pediatrics and Child Neurology at the University of Colorado and Children’s Hospital Colorado. He is currently completing a Neurogenetics Fellowship at Children’s Hospital Colorado. His clinical focus relates to the diagnosis and management of developmental epileptic encephalopathies, channelopathies, congenital brain malformations, neurodegenerative and neurometabolic disorders—with particular interest in precision therapies for neurogenetic conditions. His research is focused on the clinical features and outcomes of children with CDKL5 Deficiency Disorder, including cortical visual impairment and its potential as a biomarker for disease severity and developmental achievement.